Development and validation of a model for diagnosis of obstructive sleep apnoea in primary care.

development and validation diagnostic model obstructive sleep apnoea predictive value primary care

Journal

Respirology (Carlton, Vic.)
ISSN: 1440-1843
Titre abrégé: Respirology
Pays: Australia
ID NLM: 9616368

Informations de publication

Date de publication:
10 2021
Historique:
revised: 08 06 2021
received: 03 12 2020
accepted: 13 07 2021
pubmed: 4 8 2021
medline: 26 11 2021
entrez: 3 8 2021
Statut: ppublish

Résumé

Use of in-laboratory polysomnography (PSG) to diagnose obstructive sleep apnoea (OSA) is cost and resource intensive. Questionnaires, physical measurements and home monitors have been studied as potential simpler alternatives. This study aimed to develop a diagnostic model for OSA for use in primary care. Primary care practitioners were trained to recognize symptoms of sleep apnoea and recruited patients based on the clinical need to investigate OSA. Assessment was by symptom questionnaires, anthropomorphic measurements, digital facial photography, and a single-channel nasal flow monitor (Flow Wizard©, DiagnoseIT, Sydney, Australia) worn at home for 3 nights. The in-laboratory PSG was the reference test, with OSA defined as apnoea-hypopnoea index (AHI) ≥10 events/h. In the model development phase, 25 primary care practitioners studied 315 patients in whom they suspected OSA, of which 57% had AHI≥10 and 22% had AHI≥30. Published OSA questionnaires provided low to moderate prediction of OSA (area under the curve [AUC] 0.53-0.73). The nasal flow monitor alone yielded high accuracy for predicting OSA with AUC of 0.87. Sensitivity was 0.87 and specificity 0.77 at a threshold respiratory event index (REI) of 18 events/h. A model adding age, gender, symptoms and BMI to the nasal flow monitor REI only modestly improved OSA prediction (AUC 0.89), with similar AUC (0.88) confirmed in the validation population of 114 patients. Sleep apnoea can be diagnosed in the primary care setting with a combination of clinical judgement and portable monitor test outcomes.

Sections du résumé

BACKGROUND AND OBJECTIVE
Use of in-laboratory polysomnography (PSG) to diagnose obstructive sleep apnoea (OSA) is cost and resource intensive. Questionnaires, physical measurements and home monitors have been studied as potential simpler alternatives. This study aimed to develop a diagnostic model for OSA for use in primary care.
METHODS
Primary care practitioners were trained to recognize symptoms of sleep apnoea and recruited patients based on the clinical need to investigate OSA. Assessment was by symptom questionnaires, anthropomorphic measurements, digital facial photography, and a single-channel nasal flow monitor (Flow Wizard©, DiagnoseIT, Sydney, Australia) worn at home for 3 nights. The in-laboratory PSG was the reference test, with OSA defined as apnoea-hypopnoea index (AHI) ≥10 events/h.
RESULTS
In the model development phase, 25 primary care practitioners studied 315 patients in whom they suspected OSA, of which 57% had AHI≥10 and 22% had AHI≥30. Published OSA questionnaires provided low to moderate prediction of OSA (area under the curve [AUC] 0.53-0.73). The nasal flow monitor alone yielded high accuracy for predicting OSA with AUC of 0.87. Sensitivity was 0.87 and specificity 0.77 at a threshold respiratory event index (REI) of 18 events/h. A model adding age, gender, symptoms and BMI to the nasal flow monitor REI only modestly improved OSA prediction (AUC 0.89), with similar AUC (0.88) confirmed in the validation population of 114 patients.
CONCLUSION
Sleep apnoea can be diagnosed in the primary care setting with a combination of clinical judgement and portable monitor test outcomes.

Identifiants

pubmed: 34342088
doi: 10.1111/resp.14122
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

989-996

Investigateurs

Amanda Siebers (A)
George Dungan (G)
Sarah Dennis (S)
Lydia Makarie Rofail (LM)
Peter Buchanan (P)
Zinta Harrington (Z)
Richard Lee (R)
Andrew S L Chan (ASL)
Mark Williams (M)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 Asian Pacific Society of Respirology.

Références

Bearpark H, Elliott L, Grunstein R, Cullen S, Schneider H, Althaus W, et al. Snoring and sleep apnea. A population study in Australian men. Am J Respir Crit Care Med. 1995;151:1459-65.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-5.
Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3:310-8.
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687-98.
Kendzerska T, Mollayeva T, Gershon AS, Leung RS, Hawker G, Tomlinson G. Untreated obstructive sleep apnea and the risk for serious long-term adverse outcomes: a systematic review. Sleep Med Rev. 2014;18:49-59.
Douglas JA, Chai-Coetzer CL, McEvoy D, Naughton MT, Neill AM, Rochford P, et al. Guidelines for sleep studies in adults - a position statement of the Australasian Sleep Association. Sleep Med. 2017;36 (Suppl 1):S2-S22.
Qaseem A, Dallas P, Owens DK, Starkey M, Holty JE, Shekelle P, et al. Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from theAmerican College of Physicians. Ann Intern Med. 2014;161:210-20.
Flemons WW, Douglas NJ, Kuna ST, Rodenstein DO, Wheatley J. Access to diagnosis and treatment of patients with suspected sleep apnea. Am J Respir Crit Care Med. 2004;169:668-72.
Services Australia. Medicare Item Reports. http://medicarestatistics.humanservices.gov.au.
Hanes CA, Wong KKH, Saini B. Diagnostic pathways for obstructive sleep apnoea in the Australian community: observations from pharmacy-based CPAP providers. Sleep Breath. 2015;19:1241-8.
Netzer NC, Hoegel JJ, Loube D, Netzer CM, Hay B, Alvarez-Sala R, et al. Prevalence of symptoms and risk of sleep apnea in primary care. Chest. 2003;124:1406-14.
Chai-Coetzer CL, Antic NA, Rowland LS, Catcheside PG, Esterman A, Reed RL, et al. A simplified model of screening questionnaire and home monitoring for obstructive sleep apnoea in primary care. Thorax. 2011;66:213-9.
Chai-Coetzer CL, Antic NA, Rowland LS, Reed RL, Esterman A, Catcheside PG, et al. Primary care vs specialist sleep center management of obstructive sleep apnea and daytime sleepiness and quality of life: a randomized trial. JAMA. 2013;309:997-1004.
Chai-Coetzer CL, Antic NA, McEvoy RD. Identifying and managing sleep disorders in primary care. Lancet Respir Med. 2015;3:337-9.
Maislin G, Pack AI, Kribbs NB, Smith PL, Schwartz AR, Kline LR, et al. A survey screen for prediction of apnea. Sleep. 1995;18:158-66.
Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131:485-91.
Rowley JA, Aboussouan LS, Badr MS. The use of clinical prediction formulas in the evaluation of obstructive sleep apnea. Sleep. 2000;23:929-38.
Pang KP, Terris DJ. Screening for obstructive sleep apnea: an evidence-based analysis. Am J Otolaryngol. 2006;27:112-8.
Marti-Soler H, Hirotsu C, Marques-Vidal P, Vollenweider P, Waeber G, Preisig M, et al. The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Respir Med. 2016;4:742-8.
Lee RW, Chan AS, Grunstein RR, Cistulli PA. Craniofacial phenotyping in obstructive sleep apnea - a novel quantitative photographic approach. Sleep. 2009;32:37-45.
Ross SD, Sheinhait IA, Harrison KJ, Kvasz M, Connelly JE, Shea SA, et al. Systematic review and meta-analysis of the literature regarding the diagnosis of sleep apnea. Sleep. 2000;23:519-32.
Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-5.
Wong KK, Jankelson D, Reid A, Unger G, Dungan G, Hedner JA, et al. Diagnostic test evaluation of a nasal flow monitor for obstructive sleep apnea detection in sleep apnea research. Behav Res Methods. 2008;40:360-6.
EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep. 1992;15:173-84.
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22:667-89.
Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108:812-21.
Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2007;3:737-47.
Masa JF, Duran-Cantolla J, Capote F, Cabello M, Abad J, Garcia-Rio F, et al. Effectiveness of home single-channel nasal pressure for sleep apnea diagnosis. Sleep. 2014;37:1953-61.
Kunisaki KM, Greer N, Khalil W, Koffel E, Koeller E, MacDonald R, et al. Provider types and outcomes in obstructive sleep apnea case finding and treatment: a systematic review. Ann Intern Med. 2018;168:195-202.
McNicholas WT, Bonsignore MR, Levy P, Ryan S. Mild obstructive sleep apnoea: clinical relevance and approaches to management. Lancet Respir Med. 2016;4:826-34.
Chowdhuri S, Quan SF, Almeida F, Ayappa I, Batool-Anwar S, Budhiraja R, et al. An official American Thoracic Society research statement: impact of mild obstructive sleep apnea in adults. Am J Respir Crit Care Med. 2016;193:e37-54.
McNicholas WT. Active management of mild obstructive sleep apnoea: the evidence grows. Lancet Respir Med. 2020;8:322-3.
Bonsignore MR, Randerath W, Riha R, Smyth D, Gratziou C, Goncalves M, et al. New rules on driver licensing for patients with obstructive sleep apnoea: EU Directive 2014/85/EU. Eur Respir J. 2016;47:39-41.
Cheung K, Ishman SL, Benke JR, Collop N, Tron L, Moy N, et al. Prediction of obstructive sleep apnea using visual photographic analysis. J Clin Anesth. 2016;32:40-6.
Sutherland K, Lee RWW, Chan TO, Ng S, Hui DS, Cistulli PA. Craniofacial phenotyping in Chinese and Caucasian patients with sleep apnea: influence of ethnicity and sex. J Clin Sleep Med. 2018;14:1143-51.
Senaratna CV, Perret JL, Lowe A, Bowatte G, Abramson MJ, Thompson B, et al. Detecting sleep apnoea syndrome in primary care with screening questionnaires and the Epworth Sleepiness Scale. Med J Aust. 2019;211:65-70.
Peñacoba P, Llauger MA, Fortuna AM, Flor X, Sampol G, Pedro-Pijoan AM, et al. Primary care and sleep unit agreement in management decisions for sleep apnea: a prospective study in Spain. J Clin Sleep Med. 2020;16:1579-89.
US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FA, et al. Screening for obstructive sleep apnea in adults: US preventive services task Force recommendation statement. JAMA. 2017;317:407-14.
Sanchez-Quiroga MA, Corral J, Gomez-de-Terreros FJ, Carmona-Bernal C, Asensio-Cruz MI, Cabello M, et al. Primary care physicians can comprehensively manage sleep apnea patients: a non-inferiority randomized controlled trial. Am J Respir Crit Care Med. 2018;198:648-56.
Tarraubella N, Sanchez-de-la-Torre M, Nadal N, De Batlle J, Benitez I, Cortijo A, et al. Management of obstructive sleep apnoea in a primary care vs sleep unit setting: a randomised controlled trial. Thorax. 2018;73:1152-60.
Rofail LM, Wong KK, Unger G, Marks GB, Grunstein RR. The utility of single-channel nasal airflow pressure transducer in the diagnosis of OSA at home. Sleep. 2010;33:1097-105.

Auteurs

Julia L Chapman (JL)

Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, University of Sydney, Glebe, New South Wales, Australia.
School of Psychology and Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.

Camilla M Hoyos (CM)

Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, University of Sydney, Glebe, New South Wales, Australia.
School of Psychology and Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.

Roo Killick (R)

Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, University of Sydney, Glebe, New South Wales, Australia.

Kate Sutherland (K)

Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.

Peter A Cistulli (PA)

Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.
Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, St Leonards, New South Wales, Australia.

Nick Zwar (N)

Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland, Australia.

Brendon J Yee (BJ)

Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, University of Sydney, Glebe, New South Wales, Australia.
Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Guy Marks (G)

South Western Sydney Clinical School, University of New South Wales, New South Wales, Australia.

Ronald R Grunstein (RR)

Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, University of Sydney, Glebe, New South Wales, Australia.
Charles Perkins Centre-Royal Prince Alfred Clinic, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Keith K H Wong (KKH)

Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, University of Sydney, Glebe, New South Wales, Australia.
Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH